UnitedHealth Group (NYSE:UNH) Shares Gap Up Following Analyst Upgrade

UnitedHealth Group Incorporated (NYSE:UNH) gapped up before the market opened on Tuesday after Sanford C. Bernstein raised their price target on the stock from $405.00 to $411.00. The stock had previously closed at $281.36, but opened at $308.85. Sanford C. Bernstein currently has an outperform rating on the stock. UnitedHealth Group shares last traded at $304.0070, with a volume of 6,970,907 shares.

UNH has been the subject of a number of other research reports. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a research note on Friday, January 30th. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a research note on Wednesday, January 28th. Barclays lowered their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a research note on Friday, January 30th. Finally, Truist Financial decreased their price target on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $363.42.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalizes a 2.48% boost to 2027 Medicare Advantage payment rates, which injects roughly $13B into the MA program and removes a key margin overhang for large MA players like UnitedHealth. Trump administration finalizes better-than-feared Medicare Advantage payment rate
• Positive Sentiment: Health-insurer stocks reacted strongly in premarket/after-hours trading on the CMS decision, lifting UnitedHealth sentiment and trading activity. Health insurers rise after US lifts 2027 Medicare Advantage payment rates
• Positive Sentiment: Buy-side/independent analysts have turned more constructive: Seeking Alpha argues the CMS move materially reduces margin risk and supports a bullish repricing, and Raymond James upgraded UNH ahead of Q1. UnitedHealth: The CMS Boost Changes Everything Now Raymond James boosts UnitedHealth
• Neutral Sentiment: HSBC changed its rating from “reduce” to “hold” with a $300 price target — a modest positive signal but not an aggressive upgrade; it implies limited near-term upside from that shop.
• Neutral Sentiment: UNH is getting listed in “stocks to watch” and broad coverage across outlets as the policy and analyst mix creates a market narrative shift. Stocks to Watch: UnitedHealth, Humana, Universal Music Group, Broadcom
• Negative Sentiment: Q1 results (scheduled April 21) remain a near-term catalyst and risk — management must validate margin recovery, and prior guidance/soft results contributed to the recent selloff. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past?
• Negative Sentiment: Technical/valuation headwinds remain: UNH trades below its 200-day moving average and well under its 12‑month high, reflecting material investor skepticism that could limit near-term upside absent sustained positive execution.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. North Capital Inc. boosted its stake in UnitedHealth Group by 16.2% in the third quarter. North Capital Inc. now owns 194 shares of the healthcare conglomerate’s stock valued at $67,000 after acquiring an additional 27 shares during the last quarter. Sunflower Bank N.A. boosted its stake in UnitedHealth Group by 1.5% in the third quarter. Sunflower Bank N.A. now owns 1,916 shares of the healthcare conglomerate’s stock valued at $662,000 after acquiring an additional 28 shares during the last quarter. Axis Wealth Partners LLC boosted its stake in UnitedHealth Group by 1.7% in the third quarter. Axis Wealth Partners LLC now owns 1,631 shares of the healthcare conglomerate’s stock valued at $563,000 after acquiring an additional 28 shares during the last quarter. Abound Wealth Management lifted its stake in shares of UnitedHealth Group by 13.5% during the 3rd quarter. Abound Wealth Management now owns 244 shares of the healthcare conglomerate’s stock valued at $84,000 after buying an additional 29 shares in the last quarter. Finally, Founders Capital Management LLC lifted its stake in shares of UnitedHealth Group by 3.0% during the 4th quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate’s stock valued at $324,000 after buying an additional 29 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 8.0%

The company has a market capitalization of $275.82 billion, a PE ratio of 23.08, a PEG ratio of 1.28 and a beta of 0.40. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. The stock’s 50 day moving average is $281.61 and its 200 day moving average is $319.24.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The company had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. UnitedHealth Group’s revenue was up 12.3% compared to the same quarter last year. During the same period in the prior year, the company posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.